Literature DB >> 28433553

Identification and validation of microRNAs directly regulating the UDP-glucuronosyltransferase 1A subfamily enzymes by a functional genomics approach.

Ioannis Papageorgiou1, Michael H Court2.   

Abstract

Posttranscriptional repression of UDP-glucuronosyltransferase (UGT) 1A expression by microRNAs (miRNAs) may be an important mechanism underlying interindividual variability in drug glucuronidation. Furthermore, the UGT1A 3'-UTR shared by all UGT1A enzymes is polymorphic, containing three linked SNPs (rs10929303, rs1042640, and rs8330) that could influence miRNA binding. The aim of this study was to identify the complete complement of miRNAs that could regulate UGT1A expression through binding to the reference and/or common variant UGT1A 3'-UTR. Luciferase reporter plasmids containing either the reference or variant UGT1A 3'-UTR were screened against a 2048 human miRNA library to identify those miRNAs that decrease luciferase activity by at least 30% when co-transfected into HEK293 cells. Four novel miRNAs (miR-103b, miR-141-3p, miR-200a-3p, and miR-376b-3p) were identified that repressed both reference and variant UGT1A 3'-UTR, while two other miRNAs selectively repressed the reference (miR-1286) or variant (miR-21-3p) 3'-UTR. Deletion and mutagenesis studies confirmed the binding site location for each miRNA. rs8330 disrupted miR-1286 binding to the reference UGT1A 3'-UTR, while rs10929303 enhanced miR-21-3p binding to the variant 3'-UTR. Transfection of miR-21-3p, miR-103b, miR-141-3p, miR-200a-3p, and miR-376b-3p mimics into LS180 human intestinal cells showed repression of UGT1A1 and UGT1A6 mediated glucuronidation and mRNA without affecting UGT2B7 activity or mRNA. Furthermore, transfection of miR-21-3p, miR-141-3p, and miR-200a-3p into primary human hepatocytes, repressed UGT1A1 activity and mRNA without affecting CYP3A activity. Finally, miR-21-3p and miR-200a-3p expression were negatively correlated with UGT1A6 activity and mRNA in human liver samples. Thus, UGT1A is regulated by multiple miRNAs with some showing allele-dependent effects.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Functional genomics; Glucuronidation; UDP-glucuronosyltransferase; UGT1A; microRNA

Mesh:

Substances:

Year:  2017        PMID: 28433553      PMCID: PMC6179579          DOI: 10.1016/j.bcp.2017.04.017

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  35 in total

Review 1.  Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells.

Authors:  Marina Chekulaeva; Witold Filipowicz
Journal:  Curr Opin Cell Biol       Date:  2009-05-18       Impact factor: 8.382

2.  Regulation of UDP-glucuronosyltransferase 1A1 expression and activity by microRNA 491-3p.

Authors:  Douglas F Dluzen; Dongxiao Sun; Anna C Salzberg; Nate Jones; Ryan T Bushey; Gavin P Robertson; Philip Lazarus
Journal:  J Pharmacol Exp Ther       Date:  2014-01-07       Impact factor: 4.030

3.  Validation of serotonin (5-hydroxtryptamine) as an in vitro substrate probe for human UDP-glucuronosyltransferase (UGT) 1A6.

Authors:  Soundararajan Krishnaswamy; Su X Duan; Lisa L Von Moltke; David J Greenblatt; Michael H Court
Journal:  Drug Metab Dispos       Date:  2003-01       Impact factor: 3.922

4.  MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.

Authors:  Liang Shi; Lili Wu; Zhanguo Chen; Jianrong Yang; Xiaofei Chen; Fangyou Yu; Fang Zheng; Xiangyang Lin
Journal:  Cell Physiol Biochem       Date:  2015-04-15

5.  MicroRNA-200a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis.

Authors:  Jing-Jing Yang; Hui Tao; Wei Hu; Li-Ping Liu; Kai-Hu Shi; Zi-Yu Deng; Jun Li
Journal:  Cell Signal       Date:  2014-07-15       Impact factor: 4.315

6.  Analgesic Response to Intravenous Ketamine Is Linked to a Circulating microRNA Signature in Female Patients With Complex Regional Pain Syndrome.

Authors:  Sabrina R Douglas; Botros B Shenoda; Rehman A Qureshi; Ahmet Sacan; Guillermo M Alexander; Marielle Perreault; James E Barrett; Enrique Aradillas-Lopez; Robert J Schwartzman; Seena K Ajit
Journal:  J Pain       Date:  2015-06-11       Impact factor: 5.820

7.  Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics.

Authors:  Federico Innocenti; Deanna L Kroetz; Erin Schuetz; M Eileen Dolan; Jacqueline Ramírez; Mary Relling; Peixian Chen; Soma Das; Gary L Rosner; Mark J Ratain
Journal:  J Clin Oncol       Date:  2009-04-06       Impact factor: 44.544

Review 8.  Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios.

Authors:  J Andrew Williams; Ruth Hyland; Barry C Jones; Dennis A Smith; Susan Hurst; Theunis C Goosen; Vincent Peterkin; Jeffrey R Koup; Simon E Ball
Journal:  Drug Metab Dispos       Date:  2004-08-10       Impact factor: 3.922

9.  Population pharmacokinetic analysis and pharmacogenetics of raltegravir in HIV-positive and healthy individuals.

Authors:  Mona Arab-Alameddine; Aurélie Fayet-Mello; Rubin Lubomirov; Michael Neely; Julia di Iulio; Andrew Owen; Marta Boffito; Matthias Cavassini; Huldrych F Günthard; Katharina Rentsch; Thierry Buclin; Manel Aouri; Amalio Telenti; Laurent Arthur Decosterd; Margalida Rotger; Chantal Csajka
Journal:  Antimicrob Agents Chemother       Date:  2012-02-27       Impact factor: 5.191

10.  The microRNA.org resource: targets and expression.

Authors:  Doron Betel; Manda Wilson; Aaron Gabow; Debora S Marks; Chris Sander
Journal:  Nucleic Acids Res       Date:  2007-12-23       Impact factor: 16.971

View more
  12 in total

1.  Age-Related Changes in miRNA Expression Influence GSTZ1 and Other Drug Metabolizing Enzymes.

Authors:  Stephan C Jahn; Lauren A Gay; Claire J Weaver; Rolf Renne; Taimour Y Langaee; Peter W Stacpoole; Margaret O James
Journal:  Drug Metab Dispos       Date:  2020-05-01       Impact factor: 3.922

Review 2.  The Ontogeny of UDP-glucuronosyltransferase Enzymes, Recommendations for Future Profiling Studies and Application Through Physiologically Based Pharmacokinetic Modelling.

Authors:  Justine Badée; Stephen Fowler; Saskia N de Wildt; Abby C Collier; Stephan Schmidt; Neil Parrott
Journal:  Clin Pharmacokinet       Date:  2019-02       Impact factor: 6.447

3.  Identification and validation of the microRNA response elements in the 3'-untranslated region of the UDP glucuronosyltransferase (UGT) 2B7 and 2B15 genes by a functional genomics approach.

Authors:  Ioannis Papageorgiou; Michael H Court
Journal:  Biochem Pharmacol       Date:  2017-09-28       Impact factor: 5.858

Review 4.  Epigenetics and microRNAs in UGT1As.

Authors:  Cui-Lan Meng; Wei Zhao; Dan-Ni Zhong
Journal:  Hum Genomics       Date:  2021-05-25       Impact factor: 4.639

5.  Regulation of UGT2A1 by miR-196a-5p and miR-196b-5p.

Authors:  Aimee K Sutliff; Christy J W Watson; Gang Chen; Philip Lazarus
Journal:  J Pharmacol Exp Ther       Date:  2019-03-08       Impact factor: 4.030

6.  Investigation of circular RNAs and related genes in pulmonary fibrosis based on bioinformatics analysis.

Authors:  Liteng Yang; Xin Liu; Ning Zhang; Lifang Chen; Jingyi Xu; Wencheng Tang
Journal:  J Cell Biochem       Date:  2019-02-14       Impact factor: 4.429

Review 7.  Distinct Effects of Inflammation on Cytochrome P450 Regulation and Drug Metabolism: Lessons from Experimental Models and a Potential Role for Pharmacogenetics.

Authors:  Laura M de Jong; Wim Jiskoot; Jesse J Swen; Martijn L Manson
Journal:  Genes (Basel)       Date:  2020-12-16       Impact factor: 4.096

8.  Rifampin modulation of xeno- and endobiotic conjugating enzyme mRNA expression and associated microRNAs in human hepatocytes.

Authors:  Brandon T Gufford; Jason D Robarge; Michael T Eadon; Hongyu Gao; Hai Lin; Yunlong Liu; Zeruesenay Desta; Todd C Skaar
Journal:  Pharmacol Res Perspect       Date:  2018-03-26

Review 9.  Current trends in drug metabolism and pharmacokinetics.

Authors:  Yuhua Li; Qiang Meng; Mengbi Yang; Dongyang Liu; Xiangyu Hou; Lan Tang; Xin Wang; Yuanfeng Lyu; Xiaoyan Chen; Kexin Liu; Ai-Ming Yu; Zhong Zuo; Huichang Bi
Journal:  Acta Pharm Sin B       Date:  2019-10-18       Impact factor: 11.413

10.  Circular RNA hsa_circ_0002124 promotes hepatocellular carcinoma cell proliferation through the MAPK pathway.

Authors:  Zhigang Fang; Ruifang Fan; Ying Lu; Yanling Sun; Caihan Zhao; Lingling Liu; Xiangfu Liu
Journal:  Transl Cancer Res       Date:  2019-04       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.